Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

First Trust NYSE Arca Biotechnology Index Fund (FBT)

Delayed Data
As of Apr 21
 -1.18 / -1.13%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets (including investment borrowings) in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. It is non-diversified.

No recent news for First Trust NYSE Arca Biotechnology Index Fund.


1 month-0.43% 3 years+11.91%
3 months+9.54% 5 years+19.22%
1 year+6.21% Since inception+16.45%
Data through 04/22/2017

Quote Details

Previous close$103.97
Open day’s range102.58 – 104.04
Net asset value (NAV)102.78 (04/21/2017)
Daily volume30,364
Average volume (3 months)67,068
Data as of 7:59pm ET, 04/21/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+19.22%+16.30%
Expense Gross exp ratio0.55%1.33%
Risk 5 year sharpe ratio0.891.05
Net assets$911.2M$3.0B
Average market cap$8.8B$29.5B
Average P/E--24.1
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
NKTR Nektar Therapeutics5.75%
KITE Kite Pharma Inc4.93%
AGIO Agios Pharmaceuticals Inc4.03%
VRTX Vertex Pharmaceuticals Inc3.92%
ALNY Alnylam Pharmaceuticals Inc3.91%
MYGN Myriad Genetics Inc3.63%
INCY Incyte Corp3.49%
GRFS Grifols SA3.35%
CRL Charles River Laboratories International Inc3.34%
JUNO Juno Therapeutics Inc3.33%

Search for Jobs